Is Unicycive Therapeutics Inc (UNCY) a Bad Choice in Biotechnology Thursday?

Unicycive Therapeutics Inc (UNCY) is around the top of the Biotechnology industry according to InvestorsObserver. UNCY received an overall rating of 59, which means that it scores higher than 59 percent of all stocks. Unicycive Therapeutics Inc also achieved a score of 75 in the Biotechnology industry, putting it above 75 percent of Biotechnology stocks. Biotechnology is ranked 55 out of the 148 industries.

UNCY has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on UNCY!

See Full UNCY Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 59 means the stock is more attractive than 59 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Unicycive Therapeutics Inc Stock Today?

Unicycive Therapeutics Inc (UNCY) stock has gained 0.85% while the S&P 500 is lower by -0.6% as of 10:30 AM on Thursday, Aug 3. UNCY has risen $0.01 from the previous closing price of $1.17 on volume of 12,329 shares. Over the past year the S&P 500 is up 7.97% while UNCY has risen 59.46%. UNCY lost -$1.93 per share the over the last 12 months. Click Here to get the full Stock Report for Unicycive Therapeutics Inc stock.